EUVIMEDEUVIMED entdecken
Crossref

Decálogo de la Sociedad Española de Arteriosclerosis para disminuir la inercia terapéutica

Mariano Blasco, Pablo Pérez-Martínez, Carlos Lahoz

Clínica e Investigación en Arteriosclerosis · 2017-09 · 29 (5) · 218-223

DOI: 10.1016/j.arteri.2017.06.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clínica e Investigación en Arteriosclerosis, 2017-09. Verfasst von Mariano Blasco und 2 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Medicina, Zaragoza, España. Hauptthemen laut MEDLINE: Physician-Patient Relations, Practice Guidelines as Topic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic inertia (TI) is defined as the failure of the physician to initiate or intensify a treatment when the therapeutic goal has not been achieved. TI can be of 2types: inertia due to lack of prescription of drugs and inertia in the absence of control of a risk factor. The consequences of TI are poor control of risk factors, an increase in potentially preventable events and an increase in costs. There are factors of the doctor himself, the patient and the care organization that determine the presence of TI. Ten measures are proposed to reduce TI: to promote continuing education, to define clearly therapeutic objectives, to establish audits, to implement computerized medical records with alerts, to encourage research in this field, to disseminate clinical practice guidelines, to create motivational incentives, to organize care, to improve the doctor-patient relationship and to involve other health care providers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Physician-Patient RelationsPractice Guidelines as TopicArteriosclerosisHumansPhysiciansRisk FactorsSocieties, MedicalSpain

Stichwörter der Autor:innen

DislipidemiaDyslipidemiaHipolipidemiantesInercia terapéuticaLipid-lowering agentsTherapeutic inertia

Autor:innen und Institutionen

  • Facultad de Medicina, Zaragoza, España.
  • UGC Medicina Interna, Hospital Universitario Reina Sofía. IMIBIC/Universidad de Córdoba, Córdoba, España.
  • Unidad de Lípidos y Riesgo Vascular, Hospital Carlos III, Madrid, España. Electronic address: clahoz.hciii@salud.madrid.org.

Zitieren

APA

Blasco, M., Pérez-Martínez, P., & Lahoz, C. (2017). Decálogo de la Sociedad Española de Arteriosclerosis para disminuir la inercia terapéutica. Clínica e Investigación en Arteriosclerosis, 29(5), 218-223. https://doi.org/10.1016/j.arteri.2017.06.003

Vancouver

Blasco M, Pérez-Martínez P, Lahoz C. Decálogo de la Sociedad Española de Arteriosclerosis para disminuir la inercia terapéutica. Clínica e Investigación en Arteriosclerosis. 2017;29(5):218-223. doi:10.1016/j.arteri.2017.06.003

BibTeX
@article{Blasco2017,
  author = {Blasco, Mariano and Pérez-Martínez, Pablo and Lahoz, Carlos},
  title = {Decálogo de la Sociedad Española de Arteriosclerosis para disminuir la inercia terapéutica},
  journal = {Clínica e Investigación en Arteriosclerosis},
  year = {2017},
  volume = {29},
  number = {5},
  pages = {218--223},
  doi = {10.1016/j.arteri.2017.06.003}
}
Kostenlos starten →